Recruitment for the IMMEDIATE Proof-of-Concept Study Successfully Completed
The IMMEDIATE project has achieved a big milestone in our mission to explore the Gut-Brain-Microbiota Axis and the role of chronic inflammation in the health-to-disease transition.
Led by the Pomeranian Medical University in Szczecin (Poland), the proof-of-concept (PoC) study focused on assessing the effectiveness of the novel postbiotic pasteurised Akkermansia muciniphila MucT (PAM). Over 200 healthcare professionals working in high-stress environments were recruited, all before the planned deadline.
In our new video, the partners explain more about the whole process and what the next steps are.
Watch the video to learn more.
To better understand the scientific background of the study, read the IMMEDIATE Insight written by the study lead, Dr Karolina Skonieczna-Żydecka from the Pomeranian Medical University: Proof of Concept study | IMMEDIATE.